NOTICE, MARCH 02, 2026 SHARES (Record Id 336048)
A total of 571,429 shares will be traded as old shares as of March 03, 2026 on First North Growth Market Finland.| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10:21 | Herantis Pharma Oyj: Directed Issue | NOTICE, MARCH 02, 2026 SHARES (Record Id 336048) A total of 571,429 shares will be traded as old shares as of March 03, 2026 on First North Growth Market... ► Artikel lesen | |
| 20.02. | Herantis Pharma - Funding to support HER-096 in Phase II | Herantis Pharma has made tangible progress towards raising funds to support its Phase II proof-of-concept study for lead asset HER-096 as a potential disease-modifier for Parkinson's disease (PD). In... ► Artikel lesen | |
| 19.02. | Herantis Pharma plc: Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096 | Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson's disease, following completion of study preparations
Espoo, Finland, 19 February 2026: Herantis Pharma... ► Artikel lesen | |
| 19.02. | Herantis Pharma Oyj: Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096 | Company release, inside information, 19 February 2026 at 15:15 EET
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
Funding to support... ► Artikel lesen | |
| 11.02. | Herantis Pharma Oyj: Inside information: Herantis Pharma Plc successfully completes a directed share issue raising EUR 4.2 million | Herantis Pharma PlcCompany release, inside information, 11 February 2026 at 23:45 (EET)
Inside information: Herantis Pharma Plc successfully completes a directed share issue raising EUR 4.2 million
THE... ► Artikel lesen |
